SEC Form 4 · accession 0001209191-15-013885
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane D. Englebright
Officer — SVP and Chief Nursing Officer
Period of report
Feb 12, 2015
Accepted (ET)
Feb 13, 2015 · 7:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 12, 2015 | M | 9,892 | $11.3208 | A | 15,327 | D | |
| Common StockF1 | Feb 12, 2015 | S | 10,774 | $69.0644 | D | 4,553 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $11.3208 | Feb 12, 2015 | M | 9,892 | D | — | Jan 30, 2017 | Common Stock | 9,892 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.04 to $69.09, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The option vested at the end of fiscal years 2007, 2008 and 2009 based upon the achievement of certain annual EBITDA performance targets.